Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05002751 · ClinicalTrials.gov registry record
Quantifying Radiation Induced Vaginal Stenosis
A clinical trial of Vaginal Stricture and Vaginal Stenosis, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- 12
- Enrollment target
- 1
- Study location
NCT05002751: Recruiting study of Vaginal Stricture and Vaginal Stenosis, sponsored by University of California, San Diego.
NCT05002751 is a study of Vaginal Stricture and Vaginal Stenosis that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 12 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05002751, a study of Vaginal Stricture and Vaginal Stenosis, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Radiation (RT) affects the vagina by narrowing, tightening and scarring, termed vaginal stenosis (VS). VS occurs in up to 88% of patients treated with radiation for cervical cancer. VS is not well characterized in measurements. There is a lack of understanding of how short and tight the vagina becomes after RT. This study will use specific measurements of the vagina during the routine physician physical exam after RT in the follow up periods: after RT, 3 months, 6 months, and 12 months using a plastic commercial dilator set and length and width measurements. In addition, the study use a validated sexual health survey and a specific survey on vaginal dilation preferences to help stop VS after RT.
Primary Outcome
acquire and integrate imaging and direct patient vaginal diameter measurements to characterize VS for the computer and benchtop models
Conditions Studied
Interventions
- OTHER UCSD Vaginal Dilator Questionnaire
- OTHER EORTC Sexual Health Questionnaire
Study Locations (1)
California
- UCSD Moores Cancer Center - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-10-06 |
| Est. Completion | 2027-02-28 |
What NCT05002751 shows while recruiting
NCT05002751 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 2 conditions, with Vaginal Stricture appearing as the primary indexed condition, and to 2 interventions - of which UCSD Vaginal Dilator Questionnaire is the first listed.
NCT05002751 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05002751 about?
NCT05002751 is a clinical study titled "Quantifying Radiation Induced Vaginal Stenosis". Radiation (RT) affects the vagina by narrowing, tightening and scarring, termed vaginal stenosis (VS). VS occurs in up to 88% of patients treated with radiation for cervical cancer. VS is not well characterized in measurements. There is a lack of understanding of how short and tight the vagina becom...
What is the current status of trial NCT05002751?
This trial is currently recruiting. The enrollment target is 12 participants. The study started on 2022-10-06. Estimated completion is 2027-02-28.
What conditions does trial NCT05002751 study?
This clinical trial studies the following conditions: Vaginal Stricture, Vaginal Stenosis.
What interventions are being tested in trial NCT05002751?
The interventions under investigation include: UCSD Vaginal Dilator Questionnaire (OTHER), EORTC Sexual Health Questionnaire (OTHER).
Who is sponsoring clinical trial NCT05002751?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05002751 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI